Reversible cerebral vasoconstriction syndrome

Holly Yancy; Joyce K. Lee-Iannotti; Todd J. Schwedt; David W. Dodick

doi:10.1111/head.12040

Reversible cerebral vasoconstriction syndrome

Holly Yancy, Joyce K. Lee-Iannotti, Todd J. Schwedt, David W. Dodick

Neurology

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a cerebrovascular disorder with a clinical picture that continues to be refined. It has presented to multiple subspecialties over the past several decades, bringing with it many questions regarding risk factors, diagnosis, and management. Answers have been forthcoming but many questions remain. RCVS presents with recurrent, secondary thunderclap headaches and predominantly affects young women. The mechanism of vasoconstriction is unclear, but there has been speculation regarding a hyperadrenergic state. Diagnosis requires physician awareness, vascular imaging, and knowledge of the differential. The hallmark of its diagnosis is reversibility. Management is empiric, usually with calcium-channel blockers, as there are no controlled treatment trials for RCVS. Randomized controlled trials are needed.

Original language	English (US)
Pages (from-to)	570-576
Number of pages	7
Journal	Headache
Volume	53
Issue number	3
DOIs	https://doi.org/10.1111/head.12040
State	Published - Mar 2013

Keywords

Call-Fleming syndrome
benign angiopathy of the central nervous system
reversible cerebral vasoconstriction syndrome

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1111/head.12040

Cite this

@article{52938f012b3849c5b5a4a49b5a869dba,

title = "Reversible cerebral vasoconstriction syndrome",

abstract = "Reversible cerebral vasoconstriction syndrome (RCVS) is a cerebrovascular disorder with a clinical picture that continues to be refined. It has presented to multiple subspecialties over the past several decades, bringing with it many questions regarding risk factors, diagnosis, and management. Answers have been forthcoming but many questions remain. RCVS presents with recurrent, secondary thunderclap headaches and predominantly affects young women. The mechanism of vasoconstriction is unclear, but there has been speculation regarding a hyperadrenergic state. Diagnosis requires physician awareness, vascular imaging, and knowledge of the differential. The hallmark of its diagnosis is reversibility. Management is empiric, usually with calcium-channel blockers, as there are no controlled treatment trials for RCVS. Randomized controlled trials are needed.",

keywords = "Call-Fleming syndrome, benign angiopathy of the central nervous system, reversible cerebral vasoconstriction syndrome",

author = "Holly Yancy and Lee-Iannotti, {Joyce K.} and Schwedt, {Todd J.} and Dodick, {David W.}",

year = "2013",

month = mar,

doi = "10.1111/head.12040",

language = "English (US)",

volume = "53",

pages = "570--576",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Reversible cerebral vasoconstriction syndrome

AU - Yancy, Holly

AU - Lee-Iannotti, Joyce K.

AU - Schwedt, Todd J.

AU - Dodick, David W.

PY - 2013/3

Y1 - 2013/3

N2 - Reversible cerebral vasoconstriction syndrome (RCVS) is a cerebrovascular disorder with a clinical picture that continues to be refined. It has presented to multiple subspecialties over the past several decades, bringing with it many questions regarding risk factors, diagnosis, and management. Answers have been forthcoming but many questions remain. RCVS presents with recurrent, secondary thunderclap headaches and predominantly affects young women. The mechanism of vasoconstriction is unclear, but there has been speculation regarding a hyperadrenergic state. Diagnosis requires physician awareness, vascular imaging, and knowledge of the differential. The hallmark of its diagnosis is reversibility. Management is empiric, usually with calcium-channel blockers, as there are no controlled treatment trials for RCVS. Randomized controlled trials are needed.

AB - Reversible cerebral vasoconstriction syndrome (RCVS) is a cerebrovascular disorder with a clinical picture that continues to be refined. It has presented to multiple subspecialties over the past several decades, bringing with it many questions regarding risk factors, diagnosis, and management. Answers have been forthcoming but many questions remain. RCVS presents with recurrent, secondary thunderclap headaches and predominantly affects young women. The mechanism of vasoconstriction is unclear, but there has been speculation regarding a hyperadrenergic state. Diagnosis requires physician awareness, vascular imaging, and knowledge of the differential. The hallmark of its diagnosis is reversibility. Management is empiric, usually with calcium-channel blockers, as there are no controlled treatment trials for RCVS. Randomized controlled trials are needed.

KW - Call-Fleming syndrome

KW - benign angiopathy of the central nervous system

KW - reversible cerebral vasoconstriction syndrome

UR - http://www.scopus.com/inward/record.url?scp=84875264369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875264369&partnerID=8YFLogxK

U2 - 10.1111/head.12040

DO - 10.1111/head.12040

M3 - Review article

C2 - 23489219

AN - SCOPUS:84875264369

VL - 53

SP - 570

EP - 576

JO - Headache

JF - Headache

SN - 0017-8748

IS - 3

ER -

Reversible cerebral vasoconstriction syndrome

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this